FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Care and Connection That Matter

Access to care, trusted guidance, and meaningful programs that support individuals and families—every step of the way.

MDA Engage Community Education Seminar: New York

Saturday, June 8, 2019
Registration & Breakfast:  8:30-9:30 AM
Event: 9:30 AM-3:00 PM (lunch included)
Social Hour: 3:00-4:00 PM

Event Chair: Dr. Michio Hirano, Professor of Neurology at Columbia University Medical Center, MDA Care Center Director

Event Location: 
Convene
237 Park Avenue
New York, NY  10017

*Accessible entrance on E 45th Street between Park Avenue and Lexington Avenue

There is no cost to attend the event, however, registration is required.

Registraion Closed

Keynote Presentation:

  • Research and Clinical Trials in NMD
    • Dr. Michio Hirano, Columbia University Medical Center

Covered Topics Include:

  • Best Practices in Clinical Care
    • Dr. Leslie Delfiner, Montefiore Medical Center
  • Mental Health
    • Mary Holt-Paolone, RN, Temple University Medical Center
  • Genetic Testing
    • Dr. Heather Lau, NYU-Langone Medical Center
  • Assistive Technology for Computer Access & Environmental Control
    • Sara Feldman, PT, DPT, ATP, Temple University Medical Center

 

MDA Thanks our sponsors:

  • Sanofi Genzyme
  • Genentech

For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)